Eficacia y seguridad de eltrombopag en pacientes con diagnostico de anemia aplásica severa adquirida, sin donante HLA idéntico, candidato a terapia inmunosupresora (globulina antitimocitica y ciclosporina) / Efficacy and safety of eltrombopag in patients with a diagnosis of acquired severe aplastic anemia, without an HLA identical donor, candidate for immunosuppressive therapy (antithymocyte globulin and cyclosporine)
Lima; IETSI; set. 2023.
Non-conventional
in Spanish
| BRISA/RedTESA
| ID: biblio-1553018
Responsible library:
BR1.1
Subject(s)
Full text:
Available
Collection:
Tematic databases
Database:
BRISA/RedTESA
Main subject:
Cyclosporine
/
Receptors, Thrombopoietin
/
Immunosuppressive Agents
/
Anemia, Aplastic
Type of study:
Health technology assessment
Limits:
Humans
Language:
Spanish
Year:
2023
Document type:
Non-conventional
